Please sign in to follow a disease.
Allergic bronchopulmonary aspergillosis
MONDO:0015243Allergic bronchopulmonary aspergillosis (ABPA) is a rare immunologic pulmonary disorder caused by hypersensitivity to Aspergillus fumigatus, clinically manifesting with poorly controlled asthma and recurrent pulmonary infiltrates.
Also known as: ABPA, Hinson-Pepys disease, allergic aspergillosis, allergic bronchopulmonary aspergillosis, familial, allergic bronchopulmonary mycosis, aspergillosis, allergic bronchopulmonary
24 clinical trials for this condition and its sub-types, 15 tagged with Allergic bronchopulmonary aspergillosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Allergic bronchopulmonary aspergillosis
-
Malt worker's lung 0 trials
-
New drug could tame severe asthma and fungal allergy
Disease control Recruiting nowThis study tests a drug called benralizumab (Fasenra) in 20 adults with severe asthma and a fungal allergy called ABPA. The goal is to see if it can reduce asthma flare-ups that need steroids and improve quality of life. Participants receive the drug as a shot under the skin, and…
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New biologic combo aims to tame rare lung fungal allergy
Disease control Recruiting nowThis study looks at whether adding a biologic drug to standard treatment can reduce flare-ups in people with allergic bronchopulmonary aspergillosis (ABPA) and severe asthma. About 50 adults will receive a biologic for at least 4 months while continuing their usual asthma medicat…
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Steroid combo may improve tough lung fungus treatment
Disease control Recruiting nowThis study looks at people with a mix of two lung conditions caused by the fungus Aspergillus: chronic pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Researchers want to see if adding steroid pills to the standard antifungal drug itraconazole works better th…
Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New bronchoscopic combo treatment aims to clear mucus plugs in ABPA patients
Disease control Recruiting nowThis study is for people with allergic bronchopulmonary aspergillosis (ABPA), a lung condition caused by an allergic reaction to a fungus. The treatment involves using a bronchoscope (a thin tube inserted into the airways) to clear mucus plugs and spray an antifungal drug (amphot…
Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
AI model aims to predict dangerous lung Flare-Ups in ABPA patients
Knowledge-focused Recruiting nowThis study develops a machine learning model to predict the risk of acute exacerbation within one year in patients with allergic bronchopulmonary aspergillosis (ABPA), a lung condition caused by allergic reactions to Aspergillus fungus. Researchers will analyze data from 200 stab…
Sponsor: Qianfoshan Hospital • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
Fungal fingerprints in lungs may predict ABPA Flare-Ups
Knowledge-focused Recruiting nowThis study looks at people with allergic bronchopulmonary aspergillosis (ABPA), a lung condition caused by an allergic reaction to a common fungus. Researchers want to see if having fungus detectable in sputum or lung fluid samples is linked to more frequent flare-ups or worse ou…
Sponsor: Qianfoshan Hospital • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
AI model aims to predict ABPA relapse risk
Knowledge-focused Recruiting nowThis study is developing a machine learning model to predict the risk of relapse within one year for people with allergic bronchopulmonary aspergillosis (ABPA), a lung condition caused by an allergic reaction to a fungus. Researchers will collect data from 300 patients across mul…
Sponsor: Qianfoshan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Scientists probe immune secrets behind asthma and COPD
Knowledge-focused Recruiting nowThis study looks at how the immune system influences disease control in people with inflammatory airway diseases like asthma, COPD, and bronchiectasis. Researchers will analyze blood and sputum samples from 200 participants to find links between immune cell patterns and disease s…
Sponsor: First Affiliated Hospital of Ningbo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Mold in your home could worsen asthma – new study investigates
Knowledge-focused Recruiting nowThis study looks at how fungi in the environment (like mold in homes) affect people with asthma, allergic bronchopulmonary aspergillosis (ABPA), and bronchiectasis. Researchers will collect dust and sputum samples from 125 adults aged 18–80 and follow them for 6 months. The goal …
Sponsor: First Affiliated Hospital of Ningbo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
1500 patients join quest to decode bronchiectasis in china
Knowledge-focused Recruiting nowThis study aims to better understand bronchiectasis, a chronic lung disease, in Chinese patients. Researchers will collect data from 1500 adults to identify different disease types and their underlying causes. The goal is to improve diagnosis and tailor treatments for each patien…
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC